iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Sees Large Volume Increase – What’s Next?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) saw unusually-strong trading volume on Thursday . Approximately 175,712 shares changed hands during mid-day trading, an increase of 51% from the previous session’s volume of 116,050 shares.The stock last traded at $102.34 and had previously closed at $102.37.

iShares U.S. Pharmaceuticals ETF Trading Down 1.7%

The stock’s 50 day moving average price is $93.29 and its two-hundred day moving average price is $89.35. The firm has a market capitalization of $1.26 billion, a PE ratio of 17.75 and a beta of 0.49.

Institutional Trading of iShares U.S. Pharmaceuticals ETF

Large investors have recently made changes to their positions in the stock. Hudock Inc. lifted its holdings in iShares U.S. Pharmaceuticals ETF by 3.9% in the 4th quarter. Hudock Inc. now owns 3,034 shares of the company’s stock valued at $257,000 after purchasing an additional 114 shares in the last quarter. Sunbelt Securities Inc. grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 14.3% during the first quarter. Sunbelt Securities Inc. now owns 960 shares of the company’s stock worth $83,000 after buying an additional 120 shares in the last quarter. O Shaughnessy Asset Management LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 35.0% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after buying an additional 120 shares during the last quarter. National Bank of Canada FI raised its position in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after buying an additional 175 shares during the last quarter. Finally, Root Financial Partners LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 36.5% in the first quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock valued at $60,000 after buying an additional 186 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.